| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $430.0M | — | -9.6% |
| Cost of Revenue | $106.8M | — | +4.2% |
| Gross Profit | $323.2M | — | -13.4% |
| R&D Expense | $82.0M | — | +10.4% |
| SG&A Expense | $48.6M | — | +43.6% |
| Operating Income | $37.1M | — | -70.7% |
| Pre-tax Income | $39.7M | — | -68.6% |
| Income Tax | $6.9M | — | -83.0% |
| Net Income | $32.8M | — | -61.6% |
| EPS (Basic) | $0.19 | — | -80.8% |
| EPS (Diluted) | $0.18 | — | -80.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $270.0M | +27.1% | +16.8% |
| Short-term Investments | $204.0M | -4.4% | +45.1% |
| Accounts Receivable | $173.9M | -34.3% | -14.3% |
| Current Assets | $903.9M | -7.6% | +6.8% |
| Total Assets | $1.55B | -5.0% | +17.3% |
| Current Liabilities | $743.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $212.3M | — | +3.9% |
| Capital Expenditures | $5.7M | — | +204.6% |
| Investing Cash Flow | $2.8M | — | -98.9% |
| Financing Cash Flow | -$154.2M | — | +73.2% |
| Free Cash Flow | $206.5M | — | +2.1% |
| +22.0% |
| Total Liabilities | $845.1M | +0.1% | +18.9% |
| Stockholders' Equity | $705.9M | -10.3% | +15.5% |